Citadel Advisors’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-36,554
| Closed | -$15K | – | 5396 |
|
|
2018
Q4 | $15K | Buy |
+36,554
| New | +$15K | ﹤0.01% | 4349 |
|
|
2018
Q3 | – | Sell |
-12,022
| Closed | -$29K | – | 5053 |
|
|
2018
Q2 | $29K | Buy |
+12,022
| New | +$29K | ﹤0.01% | 3997 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 4744 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 4586 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 4464 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 4564 |
|
|
2017
Q1 | – | Sell |
-40,863
| Closed | -$79K | – | 4559 |
|
|
2016
Q4 | $79K | Buy |
40,863
+28,165
| +222% | +$54.5K | ﹤0.01% | 3264 |
|
|
2016
Q3 | $79K | Buy |
+12,698
| New | +$79K | ﹤0.01% | 3229 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 4285 |
|
|
2016
Q1 | – | Sell |
-364
| Closed | -$11K | – | 4398 |
|
|
2015
Q4 | $11K | Sell |
364
-2,778
| -88% | -$84K | ﹤0.01% | 3778 |
|
|
2015
Q3 | $99K | Sell |
3,142
-28,209
| -90% | -$889K | ﹤0.01% | 3393 |
|
|
2015
Q2 | $1.86M | Buy |
31,351
+13,360
| +74% | +$791K | ﹤0.01% | 1772 |
|
|
2015
Q1 | $1.92M | Buy |
17,991
+6,817
| +61% | +$729K | ﹤0.01% | 1820 |
|
|
2014
Q4 | $1.05M | Buy |
11,174
+10,087
| +928% | +$948K | ﹤0.01% | 2087 |
|
|
2014
Q3 | $83K | Sell |
1,087
-660
| -38% | -$50.4K | ﹤0.01% | 3098 |
|
|
2014
Q2 | $157K | Buy |
+1,747
| New | +$157K | ﹤0.01% | 2888 |
|